Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lichtenegger

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Zentralblatt Fur Gynakologie|January 1, 1993
[Surgical technique of subcutaneous/skin preserving tumor-adapted mastectomy]W D Schoenegg, U Peters, C Minguillon, et al.
Zentralblatt Fur Gynakologie|May 9, 2001
[Challenge of evidence-based medicine: sense and non-sense of diagnostic tests in gynecology]J Sehouli, D Stengel, J Hindenburg, et al.
Human Reproduction (Oxford, England)|February 1, 1996
Internal jugular vein thrombosis caused by resistance to activated protein C as a complication of ovarian hyperstimulation after in-vitro fertilizationB Horstkamp, M Lübke, H Kentenich, et al.
Onkologie|March 10, 2004
Dose finding study for combination treatment with topotecan and gemcitabine of patients with recurrent ovarian cancer after failure of first-line chemotherapy with Paclitaxel and platinumJ Sehouli, D Stengel, G Oskay, et al.
Thrombosis Research|May 12, 2009
Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO)C Fotopoulou, A Karavas, R Trappe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancerJ Sehouli, A Mustea, D Koensgen, et al.
American Journal of Obstetrics and Gynecology|April 14, 2000
Nitroglycerin application during cesarean delivery: plasma levels, fetal/maternal ratio of nitroglycerin, and effects in newbornsM David, M M Walka, B Schmid, et al.
Archives of Gynecology and Obstetrics|May 18, 1999
Comparison of various imaging methods with particular evaluation of color Doppler sonography for planning surgery for breast tumorsJ U Blohmer, H Oellinger, C Schmidt, et al.
Anticancer Research|April 19, 2006
Overexpression of the plasminogen activator inhibitor type-1 in epithelial ovarian cancerD Koensgen, A Mustea, C Denkert, et al.
Wiener Klinische Wochenschrift|September 26, 1986
[Heart function in infants and small children, whose mothers required tocolysis with hexoprenaline sulfate (Gynipral)]G Trittenwein, H Rosegger, A Beitzke, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Zentralblatt Fur Gynakologie|January 1, 1993
[Surgical technique of subcutaneous/skin preserving tumor-adapted mastectomy]W D Schoenegg, U Peters, C Minguillon, et al.
Zentralblatt Fur Gynakologie|May 9, 2001
[Challenge of evidence-based medicine: sense and non-sense of diagnostic tests in gynecology]J Sehouli, D Stengel, J Hindenburg, et al.
Human Reproduction (Oxford, England)|February 1, 1996
Internal jugular vein thrombosis caused by resistance to activated protein C as a complication of ovarian hyperstimulation after in-vitro fertilizationB Horstkamp, M Lübke, H Kentenich, et al.
Onkologie|March 10, 2004
Dose finding study for combination treatment with topotecan and gemcitabine of patients with recurrent ovarian cancer after failure of first-line chemotherapy with Paclitaxel and platinumJ Sehouli, D Stengel, G Oskay, et al.
Thrombosis Research|May 12, 2009
Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO)C Fotopoulou, A Karavas, R Trappe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancerJ Sehouli, A Mustea, D Koensgen, et al.
American Journal of Obstetrics and Gynecology|April 14, 2000
Nitroglycerin application during cesarean delivery: plasma levels, fetal/maternal ratio of nitroglycerin, and effects in newbornsM David, M M Walka, B Schmid, et al.
Archives of Gynecology and Obstetrics|May 18, 1999
Comparison of various imaging methods with particular evaluation of color Doppler sonography for planning surgery for breast tumorsJ U Blohmer, H Oellinger, C Schmidt, et al.
Anticancer Research|April 19, 2006
Overexpression of the plasminogen activator inhibitor type-1 in epithelial ovarian cancerD Koensgen, A Mustea, C Denkert, et al.
Wiener Klinische Wochenschrift|September 26, 1986
[Heart function in infants and small children, whose mothers required tocolysis with hexoprenaline sulfate (Gynipral)]G Trittenwein, H Rosegger, A Beitzke, et al.
Pageof 12